RAC race oncology ltd

6.72%

$1.27

Love your work, mate. Perhaps the oncolines-decitabine...

First 12988 Last

Share
Profile

Follow
Mason14

1,633 Posts.

13860

04/05/25

16:33

Post #: 78912440
Share

Originally posted by johndprent: ↑

Do you not read my posts, Hunterr?

I think the AML Investigator was only ever a BATNA (i.e. Plan B).

Decitabine has negligible cardiotoxicity (too rare to really warrant concern). So the synergy opportunity for the AML trial was only ever increased anti-cancer efficacy.

This means that RC220 doesn't need to be validated as a cardioprotective agent for Otsuka/Astex to see value in licensing RC220 for use in combination with Decitabine**.

Borje has already demonstrated an increase in the cytotoxicity of Decitabine (and others) when used in combination with Zan preclinically. RC220 has just been clinically validated (no Phlebitis). Now would be the perfect time to enter a joint development collaboration with the likes of Otsuka/Astex for Decitabine - or even AbbVie/Genetech for Venetoclax.

**Licensing RC220 now, prior to CPACS validation, warrants a massive $$$ increase to future licensing agreements post CPACS validation.

Expand

Love your work, mate.

Perhaps the oncolines-decitabine preclinical work has been expanded out to in vivo models.

RAC Price at posting: $1.21 Sentiment: Buy Disclosure: Held
36 Upvote

0 Great analysis

Reply

Top Stories

Almonty Industries – Now it is getting critical!

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

MTM

MTM Crit Metals hits +1,870% returns YoY – but fundamental questions remain

ASX Market Close: IT surges as Miners dumped | June 18, 2025

MEM

Many are concerned about global falling birthrates. This diverse stock has solutions

First 12988 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.27		Change 0.080(6.72%)		Mkt cap ! $220.6M

Open	High	Low	Value	Volume
$1.20	$1.30	$1.19	$207.4K	164.9K

Buyers (Bids)

No.	Vol.	Price($)
1	11	$1.28

Sellers (Offers)

Price($)	Vol.	No.
$1.35	1648	1

View Market Depth

No.	Vol.	Price($)
1	11	1.280
1	323	1.270
1	10000	1.255
1	10000	1.250
2	15566	1.200

Price($)	Vol.	No.
1.350	1648	1
1.480	263	1
1.500	1961	1
1.530	1300	1
1.535	9878	1

Last trade - 15.59pm 18/06/2025 (20 minute delay)

RAC (ASX) Chart

Love your work, mate. Perhaps the oncolines-decitabine...

Almonty Industries – Now it is getting critical!

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

MTM Crit Metals hits +1,870% returns YoY – but fundamental questions remain

ASX Market Close: IT surges as Miners dumped | June 18, 2025

Many are concerned about global falling birthrates. This diverse stock has solutions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Love your work, mate. Perhaps the oncolines-decitabine...

Top Stories

Almonty Industries – Now it is getting critical!

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

MTM Crit Metals hits +1,870% returns YoY – but fundamental questions remain

ASX Market Close: IT surges as Miners dumped | June 18, 2025

Many are concerned about global falling birthrates. This diverse stock has solutions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News